SecBot SecBot
6-K ·Filed Jul 20, 2026

ZJYL

Jin Medical International Ltd.
BEARISH
Impact 8/10
Horizonimmediate Processed3mo ago SEC0001213900-26-079674
Notable filing: 6-K
Actionable Insight ▼ Bearish

Expect severe downward pressure on ZJYL as the market prices in the massive dilution from the 64.2M-share issuance and the authorized share count increase. The entrenchment of CEO control and the lack of financial details on the Tongsheng acquisition increase uncertainty. Traders should monitor for any pricing details of the CEO share repurchase and the timeline for the acquisition closing. If the stock price falls below the US$1.641 issue price, further downside risk emerges.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ZJYL ▼ -5.94% at T+60d
SHORT call ✓ call won +5.94% · α vs SPY +9.91% · entry $2.19 → $2.06
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
+8.68%
call -8.68% · α -8.79%
$2.38
settled 3mo ago
T+5d
-8.68%
call +8.68% · α +7.45%
$2.00
settled 3mo ago
T+20d
+40.64%
call -40.64% · α -38.08%
$3.08
settled 2mo ago
T+60d
-5.94%
call +5.94% · α +9.91%
$2.06
settled 14d ago

Price Chart

Loading chart...

Executive Summary

Shareholders approved a massive authorized share capital increase from 50M to 15B shares, a 10.6x dilutive issuance of 64.2M Class A shares to acquire Beijing Tongsheng Technology via VIE agreements, and a governance overhaul that boosts CEO Wang Erqi's voting power from 30 to 800 votes per Class B share. The CEO also received approval to repurchase 3.77M of his own Class A shares at the lowest 90-day VWAP and exchange them for new Class B shares, further entrenching control. The dilution is extreme relative to the current 6.8M Class A float, and the acquisition terms lack financial disclosure, raising governance concerns.

Key Facts

  • Authorized share capital increased from US$50,000 (45M Class A + 5M Class B) to US$15,005,000 (15B Class A + 5M Class B).
  • 64,186,456 Class A shares to be issued at US$1.641/share as consideration for VIE acquisition of Beijing Tongsheng Technology Co., Ltd.
  • Voting rights of Class B shares increased from 30 votes to 800 votes per share, entrenching CEO WANG Erqi's control.
  • Company to repurchase 3,769,057 Class A shares from CEO-affiliated Jolly Harmony at lowest 90-day VWAP, then issue 3,769,057 new Class B shares to Jolly Harmony.
  • Prior 20-F (Feb 2026) showed 156.5M ordinary shares outstanding, indicating a significant reverse stock split or restructuring occurred before this filing.
  • All proposals passed with overwhelming shareholder support (>99% of votes cast).

Financial Impact

Massive dilution: 64.2M new Class A shares (10.6x current Class A float of 6.8M) at US$1.641/share, implying a deal value of ~US$105M. Combined with authorized share expansion to 15B, further dilution is authorized. CEO's share repurchase and swap further concentrates control at no net cash cost to the company.

dilutionshare countgovernancevoting control

Risk Factors

  • Extreme dilution from 64.2M new shares relative to current 6.8M float could drive stock price below US$1.641/share.
  • Authorized share count of 15B allows for further unchecked dilution without additional shareholder approval.
  • Related-party transactions (CEO share repurchase and swap) raise governance red flags and may trigger Nasdaq scrutiny.
  • Lack of financial disclosure for Tongsheng acquisition prevents valuation assessment.
  • Potential Nasdaq delisting risk if stock price falls below minimum bid price requirements.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-079674
Document: 0001213900-26-079674-index-headers.html0001213900-26-079674
Document: 0001213900-26-079674-index.html0001213900-26-079674
Document: 0001213900-26-079674.txt0001213900-26-079674
8 reports for ZJYL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZJYL — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
SC 13D/A
BEARISH ★ 6/10
$1.91awaiting T+60—$1.99 (−4.37%)
Sep 24, 2026
4w ago
6-K
BEARISH ★ 6/10
$1.91awaiting T+60—$1.99 (−4.37%)
Aug 4, 2026
11w ago
Press Release
BEARISH ★ 5/10
$2.21awaiting T+60—$1.99 (+9.80%)
Jul 20, 2026
14w ago
6-K
BEARISH ★ 8/10
$2.19 $2.06▲ +5.94%▲ +9.91%$1.99 (+8.98%)
Jun 29, 2026
17w ago
6-K
BEARISH ★ 8/10
$1.82 $2.05▼ −12.64%▼ −9.07%$1.99 (−9.53%)
Jun 4, 2026
20w ago
6-K
BEARISH ★ 6/10
$2.86 $2.34▲ +18.18%▲ +20.06%$1.99 (+30.30%)
Apr 27, 2026
26w ago
3
NEUTRAL ★ 1/10
$2.28 $2.38▲ +4.39%▼ −0.39%$1.99 (−12.57%)
Apr 7, 2026
28w ago
6-K
NEUTRAL ★ 4/10
$2.20 $1.96▼ −10.91%▼ −21.37%$1.99 (−9.39%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (17h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026